This phase IV clinical trial demonstrated that the combination of Sculptra (biostimulator) and Restylane products (hyaluronic acid fillers) delivered impressive results: Significant improvements in mid-face shape and contouring Enhanced skin quality, including significantly improving skin radiance and thickness Improved skin hydration maintained through follow-up visits High patient satisfaction, with 89% feeling more attractive and happier with their appearance The safety profile was excellent, with no treatment-related adverse events reported, confirming that these protocols are both effective and well-tolerated
International Association for Physicians in Aesthetic Medicine
Injection Site Reactions: Redness or pain at the injection site could occur
Optimal dietary patterns for prevention of chronic disease
AI helps healthcare providers determine the most effective dosing, monitor patient adherence, and optimize long-term outcomes
Most insurance policies contain exclusions for injuries resulting from unapproved substances. If a health care provider prescribes a compounded GLP-1 and the patient suffers an injury, the insurer may deny coverage for the defense, leaving the clinician personally liable